Navigation Links
New drug for hypertension

The National Chemical Laboratory (NCL) and Emcure Pharmaceuticals Ltd, a Pune-based company have jointly come out with a new drug for the treatment of hypertension. Announcing this at a press conference here on Thursday,// NCL director Sivaram and Emcure managing director Satish Mehta said the chirally pure S-Amlodipine, a product of their collaborative research, will be a great boon for the patients suffering from hypertension.

Stating that Emcure is among the first few in the world to introduce this product, they said the company has been granted permission from Drug Controller General of India for the manufacture of both bulk as well as formulations of S-Amlodipine.

Although Amlodipine is a proven therapy for the treatment of hypertension, it is commonly associated with side effects like headache, dizziness, flusing and abdominal pain, they said.But clinical study of S-Amlodipine has shown that none of the patients in the treatment group reported any such side effects, they said adding, NCL has already filed Indian and foreign patent applications. S-Amlodipine is the first of many more chirally pure drugs on which the NCL and Emcure scientists are working, they added.


'"/>




Page: 1

Related medicine news :

1. Preventing white coat hypertension
2. Risk of dementia reduced hypertension drugs
3. An hour of exercise a week cuts hypertension
4. Drug used to treat hypertension effective in countering Migraines
5. Common, cheaper drugs could be used to treat hypertension
6. Evidence against use of Beta blockers as first choice in the treatment of primary hypertension
7. Healthy lifestyle reduces the risk of developing hypertension
8. Prehypertension in the Young Leads to Hypertensive Adults
9. Hypertension, Prehypertension in Youngsters Linked With Heart Enlargement
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/16/2017)... ... August 16, 2017 , ... In a recent survey, eighty-two ... diet and exercise. In fact, cellulite can't always be eliminated by diet and exercise ... treatment available to select physicians nationwide. Dr. Kenneth Rothaus has recently added Cellulaze™ ...
(Date:8/16/2017)... ... 2017 , ... The Southeastern Telehealth Resource Center at the ... its funding from the Health Resources and Services Administration (HRSA), part of the ... time the HRSA administration has renewed its financial support to GPT since 2010 ...
(Date:8/16/2017)... ... August 16, 2017 , ... With a new PD diagnosis every ... cure. , The grants are awarded through a competitive application process and reviewed ... array of backgrounds and expertise in all areas relevant to PD research. The ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... based in Vero Beach, announced today that two of their associates were recognized ... represents professionally managed senior living communities in Florida. The awards were announced at ...
(Date:8/16/2017)... , ... August 16, 2017 , ... ... announces their latest new client win in the healthcare market, with Los Angeles-based ... to support healthcare staff and members. , AHF cares for nearly 800,000 individuals ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... , Aug. 15, 2017 Diplomat Pharmacy, ... to Michigan residents. ... Flint retail pharmacy, G-3320 Beecher Road. ... by the Food and Drug Administration, is intended to ... drowsiness, slowed breathing, and loss of consciousness. The medication ...
(Date:8/11/2017)... 2017 DarioHealth Corp. (NASDAQ: DRIO), a leading ... data solutions, today announced that it will release its ... host a conference call at 9:00am ET. The Company ... results and its strategy and outlook for the remainder ... Erez Raphael , Chief Executive Officer, and Zvi ...
(Date:8/7/2017)... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global ... Directors has approved the payment of a quarterly cash dividend ... The cash dividend of $0.24 per ... to stockholders of record as of the close of business ... to approval of the Board of Directors and may be ...
Breaking Medicine Technology: